Bo Wen

The Affiliated Yongchuan Hospital of Chongqing Medical University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

39h-index12.4kcitations148works4.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(24), Epigenetics and DNA Methylation(23), Genomics and Chromatin Dynamics(21), RNA Interference and Gene Delivery(17), RNA Research and Splicing(14)

Publications148 total

Efficacy of Robot-Assisted Training Plus Acupuncture Therapy on Lower Limb Functional Recovery in Stroke Patients: A Systematic Review and Meta-Analysis
Neurorehabilitation·2026
Glutamine metabolism and ammonia death: targeted modulation for enhanced cancer immunotherapy
Frontiers in Immunology·2025· 1 citedOpen Access
bacNeo: a computational toolkit for bacteria-derived neoantigen identification
2025Open Access
Exponential decay and finite-time blow-up for the Klein–Gordon equation with linear strong damping, nonlinear weak damping, and logarithmic nonlinearity
Journal of Inequalities and Applications·2025Open Access
The engineered bone marrow mesenchymal stem cell-derived exosome: A new strategy for the treatment of inflammatory diseases
International Immunopharmacology·2025· 2 cited
Traffic Target Recognition for 5G Millimeter-Wave Base Stations Based on Deep CNNs
2025
Figure S9 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025Open Access
Figure S1 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025Open Access
Figure S6 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025Open Access
Supplementary Table 3 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025Open Access
Figure S4 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025Open Access
Figure S2 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025Open Access
Figure S3 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025Open Access
Supplementary Table 5 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025Open Access
Figure S8 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025Open Access
Supplementary Table 4 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025Open Access
Supplementary Table 1 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025Open Access
Supplementary Table 2 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025Open Access
Data from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025Open Access
Figure S7 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025Open Access
page 1 of 8Next →

Frequent Co-authors

Jin Li(11), Andrew P. Feinberg(10), Rafael A. Irizarry(7), Hao Wu(7), Feng Zhang(7), Zhaoxiang Bian(6), Yun Liu(5), Daru Lu(5), Bing Su(5), Hui Li(5), Pin Lv(5), Lü Cheng(5), Haitao Xiao(5), Yungang He(4), Ji Qian(4), Ranjan Deka(4), Ranajit Chakraborty(4), Qianfeng Wang(4), Chengyuan Lin(4), George Q. Daley(3)